Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
STAU2 antisense RNA 1 (STAU2-AS1) is a long non-coding RNA, transcribed from the genomic region antisense to the STAU2 gene. Antisense RNAs such as STAU2-AS1 regulate gene expression through mechanisms including transcriptional interference, modulation of mRNA stability, and post-transcriptional regulation. STAU2-AS1 itself does not encode a protein and has not been characterized as a direct therapeutic target. While STAU2 (the protein) is involved in mRNA decay and neural function[1][2][4], STAU2-AS1 may be involved in regulating these processes indirectly, but its specific biological roles and disease relevance remain to be clarified[3][5]. Key distinctions: - STAU2 is a well-studied double-stranded RNA-binding protein with roles in mRNA degradation (Staufen-mediated mRNA decay) and synaptic function[1][2][4], while STAU2-AS1 is an antisense non-coding RNA with regulatory potential, but not traditionally considered a molecular target for drugs.
Not applicable; as a non-coding RNA, STAU2-AS1 does not directly interact with drugs or mediate classical mechanisms of action
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on STAU2 antisense RNA 1 (STAU2-AS1).